AMRN logo

Amarin Corporation plc (AMRN)

Profile

Full Name

Amarin Corporation plc

Ticker

NASDAQ: AMRN

Exchange

NASDAQ

Sector

Healthcare

Industry

General Drug Manufacturers

Country

Ireland

IPO

April 1, 1993

Indexes

Not included

Website

http://www.amarincorp.com

Employees

275

Key Details

Price

$15.39(-0.71%)

Market cap

$318.68M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$228.61M(-25.51% YoY)

Annual EPS

-$4.00(-33.33% YoY)

PE ratio

-

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $15.39
    AMRN price is $15.39

    30-Day Relative Volume

    0.55
    AMRN 30-day relative volume is 0.55

    Price Performance

    Price Most recent change

    -0.71%
    AMRN price was down -0.71% on Jul 25, 2025

    Price YTD change

    +57.04%
    AMRN price is up +57.04% since January 1st

    Price 1-year change

    -2.59%
    AMRN price is down -2.59% year-on-year

    Price 3-year change

    -42.57%
    AMRN price is down -42.57% over the past 3 years

    Price Range

    Price All-time high

    $28500.00
    AMRN price is currently -99.95% below its historical high of $28500.00

    Price 3-year low

    $7.00
    AMRN price is currently +119.86% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $318.68M
    AMRN market capitalization is $318.68 million

    Market cap 3-year change

    -40.15%
    AMRN market capitalization is down -40.15% over the past 3 years

    Market cap All-time high

    $8.66B
    AMRN market capitalization is currently -96.32% below its historical high of $8.66 billion

    Market cap sector rank

    58.37%
    AMRN market capitalization is higher than 58.37% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.74%
    AMRN shares outstanding is up +0.74% year-on-year

    Shares Outstanding 3-Year Change

    +4.23%
    AMRN shares outstanding is up +4.23% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.94
    AMRN beta is 0.94

    200-day SMA

    $11.30
    AMRN price is currently +36.18% above its 200-day simple moving average

    50-day SMA

    $13.90
    AMRN price is currently +10.71% above its 50-day simple moving average

    RSI

    51.18
    AMRN 14-day relative strength index is 51.18

    Volume

    0.55
    AMRN 30-day relative volume is 0.55

    ATR

    $0.64
    AMRN average true range is $0.64

    10-day Historical Volatility

    30.24%
    AMRN 10-day historical volatility is 30.24%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $228.61M
    AMRN annual revenue is $228.61 million

    Revenue Analysts estimate

    $179.69M
    AMRN annual revenue is currently +27.23% higher than the consensus analysts' forecast

    Revenue 1-year change

    -25.51%
    AMRN annual revenue is down -25.51% year-on-year

    Revenue Sector rank

    65.6%
    AMRN annual revenue is higher than 65.6% of companies in Healthcare sector

    EPS

    EPS

    -$4.00
    AMRN annual earnings per share is -$4.00

    EPS Analysts estimate

    -$2.01
    AMRN annual earnings per share is currently +99.00% higher than the consensus analysts' forecast

    EPS 1-year change

    -33.33%
    AMRN annual earnings per share is down -33.33% year-on-year

    EPS Sector rank

    23.4%
    AMRN annual earnings per share is higher than 23.4% of companies in Healthcare sector

    Profit

    Gross profit

    $81.38M
    AMRN annual gross profit is $81.38 million

    Gross margin

    35.60%
    AMRN annual gross profit margin is 35.60%

    Operating profit

    -$91.80M
    AMRN annual operating income is -$91.80 million

    Operating margin

    -40.15%
    AMRN annual operating profit margin is -40.15%

    Net income

    -$82.18M
    AMRN annual net profit is -$82.18 million

    Net margin

    -35.95%
    AMRN annual net profit margin is -35.95%

    Expenses

    Total expenses

    $320.41M
    AMRN annual total expenses is $320.41 million

    Operating expenses

    $173.18M
    AMRN annual total operating expenses is $173.18 million

    Cost of goods sold

    $147.23M
    AMRN annual cost of goods sold is $147.23 million

    Selling, general & administrative expenses

    $152.31M
    AMRN annual SGA is $152.31 million

    Depreciation and amortization

    $3.01M
    AMRN annual depreciation & amortization is $3.01 million

    Interest expense

    $7000.00
    AMRN annual interest expense is $7000.00

    Income tax

    $4.98M
    AMRN annual income tax is $4.98 million

    EBIT & EBITDA

    EBIT

    -$77.19M
    AMRN annual earnings before interest & taxes is -$77.19 million

    EBITDA

    -$74.18M
    AMRN annual EBITDA is -$74.18 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $685.35M
    AMRN annual total assets is $685.35 million

    Non current assets

    $89.95M
    AMRN annual long term assets is $89.95 million

    Current assets

    $595.40M
    AMRN annual total current assets is $595.40 million

    Cash and cash equivalents

    $121.04M
    AMRN annual cash & cash equivalents is $121.04 million

    Accounts receivable

    $122.28M
    AMRN annual accounts receivable is $122.28 million

    Inventory

    $166.05M
    AMRN annual inventory is $166.05 million

    Liabilities

    Total liabilities

    $199.17M
    AMRN annual total liabilities is $199.17 million

    Long term liabilities

    $19.22M
    AMRN annual total long term liabilities is $19.22 million

    Current liabilities

    $179.95M
    AMRN annual total current liabilities is $179.95 million

    Accounts payable

    $40.37M
    AMRN annual accounts payable is $40.37 million

    Debt

    Total debt

    $7.72M
    AMRN annual total debt is $7.72 million

    Total debt 1-year change

    -11.61%
    AMRN annual total debt is down -11.61% year-on-year

    Long term debt

    $7.72M
    AMRN annual long term debt is $7.72 million

    Short term debt

    -
    AMRN annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $486.18M
    AMRN annual stockholders equity is $486.18 million

    Book value

    $486.18M
    AMRN annual book value is $486.18 million

    Retained earnings

    -$1.67B
    AMRN annual retained earnings is -$1.67 billion

    Working capital

    $415.45M
    AMRN annual working capital is $415.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$31.02M
    AMRN annual cash flow from operations is -$31.02 million

    Cash from operations 1-year change

    -550.87%
    AMRN annual cash flow from operations is down -550.87% year-on-year

    Cash from investing

    -$45.98M
    AMRN annual cash flow from investing activities is -$45.98 million

    Cash from investing 1-year change

    -80.14%
    AMRN annual cash flow from investing activities is down -80.14% year-on-year

    Cash from financing

    -$1.44M
    AMRN annual cash flow from financing activities is -$1.44 million

    Cash from financing 1-year change

    -727.39%
    AMRN annual cash flow from financing activities is down -727.39% year-on-year

    CAPEX

    CAPEX

    -
    AMRN annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    AMRN annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$31.02M
    AMRN annual free cash flow is -$31.02 million

    Free cash flow 1-year change

    -588.73%
    AMRN annual free cash flow is down -588.73% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    35.60%
    AMRN annual gross profit margin is 35.60%

    Operating margin

    -40.15%
    AMRN annual operating profit margin is -40.15%

    Net margin

    -35.95%
    AMRN annual net profit margin is -35.95%

    ROA & ROE

    ROA

    -10.83%
    AMRN annual return on assets is -10.83%

    ROE

    -15.83%
    AMRN annual return on equity is -15.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AMRN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AMRN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.67
    AMRN price to book ratio is 0.67

    PB ratio Sector rank

    29.53%
    AMRN price to book ratio is higher than 29.53% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.49
    AMRN price to sales ratio is 1.49

    PS ratio Sector rank

    31.73%
    AMRN price to sales ratio is higher than 31.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $207.10M
    AMRN enterprise value is $207.10 million

    Enterprise value Sector rank

    53.46%
    AMRN enterprise value is higher than 53.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.68
    AMRN EV/EBITDA is -2.68

    EV/EBITDA Sector rank

    36.44%
    AMRN EV/EBITDA is higher than 36.44% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.31
    AMRN annual current ratio is 3.31

    Quick ratio

    2.39
    AMRN annual quick ratio is 2.39

    Leverage

    Debt to equity

    0.00
    AMRN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -11.03K
    AMRN annual interest coverage ratio is -11.03 thousand

    Risk & Stability

    Piotroski F-Score

    4
    AMRN piotroski f-score is 4

    Altman Z-Score

    -1.76
    AMRN altman z-score is -1.76

    Analyst ratings

    Recent major analysts updates

    Jun 25, 25 Goldman Sachs
    Sell
    Apr 17, 25 Goldman Sachs
    Sell
    Jun 20, 24 Cantor Fitzgerald
    Overweight
    Jun 18, 24 Cantor Fitzgerald
    Overweight
    Oct 25, 23 Jefferies
    Hold
    Jul 20, 23 Goldman Sachs
    Sell
    Jul 19, 23 Northland Capital Markets
    Market Perform
    Jan 6, 23 Jefferies
    Buy
    Oct 19, 22 SVB Leerink
    Market Perform
    May 24, 22 Goldman Sachs
    Sell

    Institutional Ownership

    Screeners with AMRN included

    Growing Shares Outstanding
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    Stocks above analysts price target
    Stocks recommended to sell
    NASDAQ Listed Companies
    Best performing stocks YTD
    • What is the ticker symbol for Amarin Corporation plc?
    • Does Amarin Corporation plc pay dividends?
    • What sector is Amarin Corporation plc in?
    • What industry is Amarin Corporation plc in?
    • What country is Amarin Corporation plc based in?
    • When did Amarin Corporation plc go public?
    • Is Amarin Corporation plc in the S&P 500?
    • Is Amarin Corporation plc in the NASDAQ 100?
    • Is Amarin Corporation plc in the Dow Jones?
    • When was Amarin Corporation plc's last earnings report?
    • When does Amarin Corporation plc report earnings?

    What is the ticker symbol for Amarin Corporation plc?

    The ticker symbol for Amarin Corporation plc is NASDAQ:AMRN

    Does Amarin Corporation plc pay dividends?

    No, Amarin Corporation plc does not pay dividends

    What sector is Amarin Corporation plc in?

    Amarin Corporation plc is in the Healthcare sector

    What industry is Amarin Corporation plc in?

    Amarin Corporation plc is in the General Drug Manufacturers industry

    What country is Amarin Corporation plc based in?

    Amarin Corporation plc is headquartered in Ireland

    When did Amarin Corporation plc go public?

    Amarin Corporation plc's initial public offering (IPO) was on April 1, 1993

    Is Amarin Corporation plc in the S&P 500?

    No, Amarin Corporation plc is not included in the S&P 500 index

    Is Amarin Corporation plc in the NASDAQ 100?

    No, Amarin Corporation plc is not included in the NASDAQ 100 index

    Is Amarin Corporation plc in the Dow Jones?

    No, Amarin Corporation plc is not included in the Dow Jones index

    When was Amarin Corporation plc's last earnings report?

    Amarin Corporation plc's most recent earnings report was on May 7, 2025

    When does Amarin Corporation plc report earnings?

    The next expected earnings date for Amarin Corporation plc is July 30, 2025
    On this page